Unlike personalized tumor-informed assays that require patient-specific sequencing, our panel-based approach offers a scalable, off-the-shelf method for high-depth ctDNA profiling in NF1-associated MPNST. Here, NF1 is linked to malignant peripheral nerve sheath tumor.